International mpox trial finds no clinical benefit from tecovirimat
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox compared with placebo, ...
Mar 2, 2026
0
8








